Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines

[en] Background: It is more and more recognized that hypoxia plays a role in the resistance of cancer cells to chemotherapy. However, the mechanisms underlying this resistance still need deeper understanding. The aim of this study was to investigate the effect of hypoxia on this process since hypoxia is one of the hallmarks of tumor environment. Results: The effect of hypoxia on the apoptosis induced by etoposide, one drug commonly used in chemotherapy, was investigated using three different cancer cell lines. Gene expression changes were also studied in order to delineate the mechanisms responsible for the hypoxia-induced chemoresistance. We observed that hypoxia differentially influenced etoposide-induced cell death according to the cancer cell type. While hypoxia inhibited apoptosis in hepatoma HepG2 cells, it had no influence in lung carcinoma A549 cells and further enhanced it in breast cancer MCF-7 cells. Etoposide increased p53 activity in all cell lines while hypoxia alone decreased it only in HepG2 cells. Hypoxia had no influence on the etoposide-induced p53 activity in A549, increased p53 abundance in MCF-7 cells but markedly decreased p53 activity in HepG2 cells. Using low density DNA arrays to detect the expression of genes involved in the regulation of apoptosis, etoposide and hypoxia were shown to each influence the expression of numerous genes, many of the ones influenced by etoposide being p53 target genes. Again, the influence of hypoxia on the etoposideinduced changes was different according to the cell type. Conclusion: These results evidenced that there was a striking parallelism between the effect of hypoxia on the etoposide-induced p53 stabilization as well as p53 target gene expression and its effect on the etoposide-induced apoptosis according to the cell type. They are very interesting not only because they provide one possible mechanism for the induction of chemoresistance under hypoxic conditions in cells like HepG2 but also because they indicate that not all cell types respond the same way. This knowledge is of importance in designing adequate treatment according to the type of tumors.

Disciplines :

Oncology

Author, co-author :

Cosse, Jean-Philippe ; Université de Liège - ULiège > GIGA-R : Epigénétique Cellulaire et Moléculaire

Sermeus, Audrey

Vannuvel, Kayleen

Ninane, Noelle

Raes, Martine

Michiels, Carine

Language :

English

Title :

Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines

Publication date :

2007

Journal title :

Molecular Cancer

eISSN :

1476-4598

Publisher :

BioMed Central, United Kingdom

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 15 February 2011

Statistics

Number of views

65 (1 by ULiège)

Number of downloads

1 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Harris AL Hypoxia - a key regulatory factor in tumour growth Nat Rev Cancer 2002, 2(1):38-47 10.1038/nrc704 11902584
Brown JM The hypoxic cell: A target for selective cancer therapy - eighteenth Bruce F. Cain Memorial Award lecture Cancer Res 1999, 59(23):5863-5870 10606224
Zhong H De Marzo AM Laughner E Lim M Hilton DA Zagzag D Buechler P Isaacs WB Semenza GL Simons JW Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases Cancer Res 1999, 59(22):5830-5835 10582706
Vaupel P Harrison L Tumor hypoxia: Causative factors, compensatory mechanisms, and cellular response Oncologist 2004, 9(Suppl 5):4-9 10.1634/theoncologist.9-90005-4 15591417
Hockel M Schlenger K Aral B Mitze M Schaffer U Vaupel P Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix Cancer Res 1996, 56(19):4509-4515 8813149
Evans SM Koch CJ Prognostic significance of tumor oxygenation in humans Cancer Lett 2003, 195(1): 1-16 10.1016/S0304-3835(03)00012-0 12767506
Harrison L Blackwell K Hypoxia and anemia: Factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist 2004, 9(Suppl 5):31-40 10.1634/theoncologist.9-90005-31 15591420
Semenza GL Targeting HIF-1 for cancer therapy Nat Rev Cancer 2003, 3(10):721-732 10.1038/nrc1187 13130303
Ivan M Kondo K Yang H Kim W Valiando J Ohh M Salic A Asara JM Lane WS Kaelin WG Jr. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing Science 2001, 292(5516):464-468 11292862
Jaakkola P Mole DR Tian YM Wilson MI Gielbert J Gaskell SJ Kriegsheim A Hebestreit HF Mukherji M Schofield CJ Maxwell PH Pugh CW Ratcliffe PJ Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation Science 2001, 292(5516):468-472 11292861
Lando D Peet DJ Gorman JJ Whelan DA Whitelaw ML Bruick RK FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor Genes Dev 2002, 16(12):1466-1471 186346 12080085 10.1101/gad.991402
Piret JP Mottet D Raes M Michiels C Is HIF-1alpha a pro- or an anti-apoptotic protein? Biochem Pharmacol 2002, 64(5-6):889-892 10.1016/ S0006-2952(02)01155-3 12213583
Greijer AE van der Wall E The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis J Clin Pathol 2004, 57(10):1009-1014 10.1136/jcp.2003.015032 15452150 1770458
An WG Kanekal M Simon MC Maltepe E Blagosklonny MV Neckers LM Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha Nature 1998, 392(6674):405-408 10.1038/32925 9537326
Zhou J Schmid T Schnitzer S Brune B Tumor hypoxia and cancer progression Cancer Lett 200,6 237(1):10-21 10.1016/j.canlet.2005.05.028 16002209
Bruick RK Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia Proc Natl Acad Sci U S A 2000, 97(16):9082-9087 16825 10922063 10.1073/pnas.97.16.9082
Lee MJ Kim JY Suk K Park JH Identification of the hypoxia-inducible factor 1 alpha-responsive HGTD-P gene as a mediator in the mitochondrial apoptotic pathway Mol Cell Biol 2004, 24(9):3918-3927 387743 15082785 10.1128/MCB.24.9.3918-3927.2004
Tanaka T Miyata T Inagi R Kurokawa K Adler S Fujita T Nangaku M Hypoxia-induced apoptosis in cultured glomerular endothelial cells: involvement of mitochondrial pathways Kidney Int 2003, 64(6):2020-2032 10.1046/j.1523-1755.2003.00301.x 14633124
Karpinich NO Tafani M Rothman RJ Russo MA Farber JL The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c J Biol Chem 2002, 277(19):16547-16552 10.1074/jbc.M110629200 11864976
Piret JP Cosse JP Ninane N Raes M Michiels C Hypoxia protects HepG2 cells against etoposide-induced apoptosis VIA a HIF-1-independent pathway Exp Cell Res 2006, 16844113
Rogakou EP Pilch DR Orr AH Ivanova VS Bonner WM DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139 J Biol Chem 1998, 273(10):5858-5868 10.1074/jbc.273.10.5858 9488723
Fels DR Koumenis C HIF-1alpha and p53: The ODD couple? Trends Biochem Sci 2005, 30(8):426-429 10.1016/j.tibs.2005.06.009 15996866
Hubert A Paris S Piret JP Ninane N Raes M Michiels C Casein kinase 2 inhibition decreases hypoxia-inducible factor-1 activity under hypoxia through elevated p53 protein level J Cell Sci 2006, 119(Pt 16):3351-3362 10.1242/jcs.03069 16882692
Koumenis C Alarcon R Hammond E Sutphin P Hoffman W Murphy M Derr J Taya Y Lowe SW Kastan M Giaccia A Regulation of p53 by hypoxia: Dissociation of transcriptional repression and apoptosis from p53-dependent transactivation Mol Cell Biol 2001, 21(4):1297-1310 99582 11158315 10.1128/MCB.21.4.1297-1310.2001
Pan Y Oprysko PR Asham AM Koch CJ Simon MC p53 cannot be induced by hypoxia alone but responds to the hypoxic microenvironment Oncogene 2004, 23(29):4975-4983 10.1038/sj.onc.1207657 15107830
Suzuki H Tomida A Tsuruo T Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia Oncogene 2001, 20(41):5779-5788 10.1038/sj.onc.1204742 11593383
Chi JT Wang Z Nuyten DS Rodriguez EH Schaner ME Salim A Wang Y Kristensen GB Helland A Borresen-Dale AL Giaccia A Longaker MT Hastie T Yang GP Vijver MJ Brown PO Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human Cancers PLoS Med 2006, 3(3):e47 1334226 16417408 10.1371/ journal.pmed.0030047
Moll UM Wolff S Speidel D Deppert W Transcription-independent pro-apoptotic functions of p53 Curr Opin Cell Biol 2005, 17(6):631-636 10.1016/j.ceb.2005.09.007 16226451
Kim M Park SY Pai HS Kim TH Billiar TR Seol DW Hypoxia inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by blocking Bax translocation Cancer Res 2004, 64(12):4078-4081 10.1158/ 0008-5472.CAN-04-0284 15205314
Erler JT Cawthorne CJ Williams KJ Koritzinsky M Wouters BG Wilson C Miller C Demonacos C Stratford IJ Dive C Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance Mol Cell Biol 2004, 24(7):2875-2889 371100 15024076 10.1128/ MCB.24.7.2875-2889.2004
Krieg AJ Hammond EM Giaccia AJ Functional analysis of p53 binding under differential stresses Mol Cell Biol 2006, 26(19):7030-7045 1592883 16980608 10.1128/MCB.00322-06
Koshiji M Kageyama Y Pete EA Horikawa I Barrett JC Huang LE HIF-1alpha induces cell cycle arrest by functionally counteracting Myc Embo J 2004, 23(9):1949-1956 404317 15071503 10.1038/sj.emboj.7600196
Wang J Biju MP Wang MH Haase VH Dong Z Cytoprotective effects of hypoxia against cisplatin-induced tubular cell apoptosis: Involvement of mitochondrial inhibition and p53 suppression J Am Soc Nephrol 2006, 17(7):1875-1885 10.1681/ASN.2005121371 16762987
Bjorling-Poulsen M Issinger OG cDNA array analysis of alterations in gene expression in the promyelocytic leukemia cell line, HL-60, after apoptosis induction with etoposide Apoptosis 2003, 8(4):377-388 10.1023/ A:1024177119658 12815281
Lozano J Menendez S Morales A Ehleiter D Liao WC Wagman R Haimovitz-Friedman A Fuks Z Kolesnick R Cell autonomous apoptosis defects in acid sphingomyelinase knockout fibroblasts J Biol Chem 2001 276, 1:442-448 10.1074/jbc.M006353200 11031259
Wellington CL Ellerby LM Hackam AS Margolis RL Trifiro MA Singaraja R McCutcheon K Salvesen GS Propp SS Bromm M Rowland KJ Zhang T Rasper D Roy S Thornberry N Pinsky L Kakizuka A Ross CA Nicholson DW Bredesen DE Hayden MR Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract J Biol Chem 1998, 273(15):9158-9167 10.1074/ jbc.273.15.9158 9535906
Chen Y Takeshita A Ozaki K Kitano S Hanazawa S Transcriptional regulation by transforming growth factor beta of the expression of retinoic acid and retinoid X receptor genes in osteoblastic cells is mediated through AP-1 J Biol Chem 1996, 271(49):31602-31606 10.1074/ jbc.271.49.31602 8940178
Kern SE Pietenpol JA Thiagalingam S Seymour A Kinzler KW Vogelstein B Oncogenic forms of p53 inhibit p53-regulated gene expression Science 1992, 256(5058):827-830 10.1126/science.1589764 1589764
de Longueville F Surry D Meneses-Lorente G Bertholet V Talbot V Evrard S Chandelier N Pike A Worboys P Rasson JP Le Bourdelles B Remacle J Gene expression profiling of drug metabolism and toxicology markers using a low-density DNA microarray Biochem Pharmacol 2002, 64(1):137-149 10.1016/ S0006-2952(02)01055-9 12106614
de Longueville F Atienzar FA Marcq L Dufrane S Evrard S Wouters L Leroux F Bertholet V Gerin B Whomsley R Arnould T Remacle J Canning M Use of a low-density microarray for studying gene expression patterns induced by hepatotoxicants on primary cultures of rat hepatocytes Toxicol Sci 2003, 75(2):378-392 10.1093/toxsci/kfg196 12883083
Debacq-Chainiaux F Borlon C Pascal T Royer V Eliaers F Ninane N Carrard G Friguet B de Longueville F Boffe S Remacle J Toussaint O Repeated exposure of human skin fibroblasts to UVB at subcytotoxic level triggers premature senescence through the TGF-beta1 signaling pathway J Cell Sci 2005, 118(Pt 4):743-758 10.1242/jcs.01651 15671065